Anti-CCL4/MIP-1 beta antibody [EP521Y]
- RabMAb
- Recombinant
- KO Validated
- What is this?
1
(1 Review)
|
(14 Publications)
Rabbit Recombinant Monoclonal CCL4/MIP-1 beta antibody. Suitable for IP, ELISA, WB, ICC/IF and reacts with Human, Mouse samples. Cited in 14 publications.
View Alternative Names
LAG1, MIP1B, SCYA4, CCL4, C-C motif chemokine 4, G-26 T-lymphocyte-secreted protein, HC21, Lymphocyte activation gene 1 protein, MIP-1-beta(1-69), Macrophage inflammatory protein 1-beta, PAT 744, Protein H400, SIS-gamma, Small-inducible cytokine A4, T-cell activation protein 2, LAG-1, MIP-1-beta, ACT-2
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-CCL4/MIP-1 beta antibody [EP521Y] (AB45690)
Immunocytochemistry/Immunofluorescence analysis of THP-1 (Human monocytic leukemia cell line) cells labeling CCL4/MIP-1 beta + CCL4L with ab45690 at 1/100. Cells were fixed with 4% Paraformaldehyde and permeabilized with 0.1% Triton X-100. ab150077 Alexa Fluor® 488-conjugated goat anti-rabbit IgG (1/1000) was used as the secondary antibody. Cells were counter-stained with ab7291 ab195889 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) at 1/200 dilution. DAPI was used to stain nuclei blue.
The expression increased after treatment with Lipopolysaccharides (LPS) 100 ng/mL for 4 hours followed by addition of Brefeldin A (1 μg/mL) for 3 hours.
- IP
Lab
Immunoprecipitation - Anti-CCL4/MIP-1 beta antibody [EP521Y] (AB45690)
ab45690 at 1/60 immunoprecipitating CCL4/MIP-1 beta + CCL4L in THP-1 (Human monocytic leukemia cell line) whole cell lysate observed at 12 KDa (lanes 1 and 2).
Lane 1 (input) : THP-1 treated with 100 nM PMA overnight, then treated with 100 ng/mL LPS for 7 hours and 1 μg/mL Brefeldin A was added for the last 3 hours whole cell lysate, 10μg
Lane 2 (+) : ab45690 + THP-1 treated with 100 nM PMA overnight, then treated with 100 ng/mL LPS for 7 hours and 1 μg/mL Brefeldin A was added for the last 3 hours whole cell lysate
Lane 3 (-) : Rabbit monoclonal IgG (ab172730) instead of ab45690 in THP-1 treated with 100 nM PMA overnight, then treated with 100 ng/mL LPS for 7 hours and 1 μg/mL Brefeldin A was added for the last 3 hours whole cell lysate
For western blotting, ab45690 at 1/1000 and ab131366 VeriBlot for IP Detection Reagent (HRP) was used for detection (1/1000).
Blocking/Diluting buffer 5% NFDM/TBST
All lanes:
Immunoprecipitation - Anti-CCL4/MIP-1 beta antibody [EP521Y] (ab45690)
Predicted band size: 10 kDa
false
Exposure time: 3min
- ELISA
Lab
ELISA - Anti-CCL4/MIP-1 beta antibody [EP521Y] (AB45690)
ELISA analysis of Human CCL4/MIP-1 beta recombinant protein at 500 ng/mL with ab45690. An Alkaline Phosphatase-conjugated AffiniPure Goat Anti-Rabbit IgG (H+L) at 1/2500 dilution was used as the secondary antibody.
- WB
Lab
Western blot - Anti-CCL4/MIP-1 beta antibody [EP521Y] (AB45690)
Blocking/Diluting buffer and concentration 5% NFDM /TBST.
CCL4/MIP-1 beta is induced in macrophages following exposure to bacterial LPS (PMID : 9848081).
All lanes:
Western blot - Anti-CCL4/MIP-1 beta antibody [EP521Y] (ab45690) at 1/1000 dilution
Lane 1:
Untreated THP-1 (human acute monocytic leukemia) cell lysate at 10 µg
Lane 2:
THP-1 treated with 100 nM Phorbol-12-myristate-13-acetate(PMA) overnight, then treated with Lipopolysaccharides (LPS) 100 ng/mL for 7 hours and then 1 µg/mL Brefeldin A was added for the last 3 hours, lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 10 kDa
Observed band size: 12 kDa
false
Exposure time: 3min
- WB
Lab
Western blot - Anti-CCL4/MIP-1 beta antibody [EP521Y] (AB45690)
False colour image of Western blot : Anti-CCL4/MIP-1 beta antibody [EP521Y] staining at 1/1000 dilution, shown in green; Mouse anti-Alpha Tubulin [DM1A] (ab7291) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab45690 was shown to bind specifically to CCL4/MIP-1 beta. A band was observed at 12 kDa in wild-type THP-1 cell lysates with no signal observed at this size in CCL4 knockout cell line ab273719 (knockout cell lysate ab275512). To generate this image, wild-type and CCL4 knockout THP-1 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) at 1/20000 dilution.
All lanes:
Western blot - Anti-CCL4/MIP-1 beta antibody [EP521Y] (ab45690) at 1/1000 dilution
Lane 1:
Wild-type THP-1 Vehicle control + Brefeldin A (5 u/mL, 6 h) cell lysate at 20 µg
Lane 2:
Wild-type THP-1 Treated PMA (100 ng/mL, 56 h) + LPS (1 u/mL, 24 h) + Brefeldin A (5 u/mL, 6 h) cell lysate at 20 µg
Lane 2:
Western blot - Human CCL4 knockout THP-1 cell line (<a href='/en-us/products/cell-lines/human-ccl4-knockout-thp-1-cell-line-ab273719'>ab273719</a>)
Lane 3:
CCL4 knockout THP-1 Vehicle control + Brefeldin A (5 u/mL, 6 h) cell lysate at 20 µg
Lane 4:
CCL4 knockout THP-1 Treated PMA (100 ng/mL, 56 h) + LPS (1 u/mL, 24 h) + Brefeldin A (5 u/mL, 6 h) cell lysate at 20 µg
Predicted band size: 10 kDa
Observed band size: 12 kDa
false
- WB
Lab
Western blot - Anti-CCL4/MIP-1 beta antibody [EP521Y] (AB45690)
Blocking/Diluting buffer and concentration 5% NFDM /TBST
All lanes:
Western blot - Anti-CCL4/MIP-1 beta antibody [EP521Y] (ab45690) at 1/1000 dilution
Lane 1:
Untreated Raw264.7 (mouse abelson murine leukemia virus-induced tumor) whole cell lysate at 10 µg
Lane 2:
Raw264.7 (mouse abelson murine leukemia virus-induced tumor) treated with LPS 10μg/mL for 4 hours and then 1 μg/mL Brefeldin A was added for the last 3 hours lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 10 kDa,18 kDa,25 kDa,55 kDa,57 kDa
Observed band size: 12 kDa,18 kDa,26 kDa,90 kDa
false
Exposure time: 3min
- WB
Lab
Western blot - Anti-CCL4/MIP-1 beta antibody [EP521Y] (AB45690)
Blocking/Diluting buffer and concentration 5% NFDM /TBST
All lanes:
Western blot - Anti-CCL4/MIP-1 beta antibody [EP521Y] (ab45690) at 1/1000 dilution
Lane 1:
Untagged human CCL4 recombinant protein (aa24-92) at 10 µg
Lane 2:
Untagged human CCL4L recombinant protein (aa24-92) at 10 µg
Lane 3:
GST-tagged human CCL3 recombinant protein (aa27-92) at 10 µg
Lane 4:
GST-tagged human CCL3L recombinant protein 2*(aa28-93) at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 10 kDa
Observed band size: 12 kDa
false
Exposure time: 5s
Related conjugates and formulations (7)
-
Anti-CCL4/MIP-1 beta antibody [EP521Y] - BSA and Azide free
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-CCL4/MIP-1 beta antibody [EP521Y]
-
660 APC
APC Anti-CCL4/MIP-1 beta antibody [EP521Y]
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-CCL4/MIP-1 beta antibody [EP521Y]
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-CCL4/MIP-1 beta antibody [EP521Y]
-
578 PE
PE Anti-CCL4/MIP-1 beta antibody [EP521Y]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-CCL4/MIP-1 beta antibody [EP521Y]
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
CCL4 is critical in immune system modulation. It coordinates leukocyte activation and trafficking contributing to inflammation and immune surveillance. It does not function in isolation but rather interacts with other chemokines and receptors. CCL4 alongside its sibling chemokines forms a dynamic network that ensures a balanced immune response. It connects to receptors such as CCR5 playing substantial roles in its activities.
Pathways
CCL4 participates in essential signaling cascades that mediate immune responses. It is notably part of the chemokine signaling pathway which is instrumental in directing cell movement. CCL4 also engages with proteins like CCR5 in the inflammatory and immune response pathways. This interaction enhances communication between cells required for effective pathogen defense.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (14)
Recent publications for all applications. Explore the full list and refine your search
Nature communications 16:3516 PubMed40229254
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 16:175 PubMed40089481
2025
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 24: PubMed37373025
2023
Applications
Unspecified application
Species
Unspecified reactive species
Mediators of inflammation 2022:1875736 PubMed36387933
2022
Applications
Unspecified application
Species
Unspecified reactive species
Journal of oncology 2022:5864826 PubMed36131790
2022
Applications
Unspecified application
Species
Unspecified reactive species
Immunity & ageing : I & A 19:34 PubMed35879802
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in molecular biosciences 8:697273 PubMed34790697
2021
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in molecular biosciences 8:682367 PubMed34179086
2021
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cell and developmental biology 9:596484 PubMed33777927
2021
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in immunology 11:366 PubMed32194569
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com